What is the current stock price of Lipella Pharmaceuticals Inc. (LIPO)?

As of the latest market data, Lipella Pharmaceuticals Inc. (LIPO) is trading at $0.04. The stock has seen a loss of 0.00% today.

Does Lipella Pharmaceuticals Inc. (LIPO) pay a dividend?

Based on current data, Lipella Pharmaceuticals Inc. does not have a confirmed active dividend policy.

What is the market cap of Lipella Pharmaceuticals Inc.?

The current market capitalization of Lipella Pharmaceuticals Inc. (LIPO) is approximately unavailable.

LIPO

Lipella Pharmaceuticals Inc.·Healthcare

0.04

0.000%(+0.00)

Market Closed

0.04

18.571%(+0.01)

After Hours

Last Updated: — ET

52W L: $0.0152W H: $3.17

LIPO NEWS

globenewswire.com

Mar 30

Lipella Pharmaceuticals Inc. Files Voluntary Petitions for Relief Under Chapter 11

PITTSBURGH, March 30, 2026 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (“Lipella” or the “Company”), a clinical-stage biotechnology company, announced today that it filed a voluntary petition for relief under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the Western District of Pennsylvania (the “Court”). The Company intends to undergo a 363 sale process under Chapter 11 in order to maximize value for creditors.

Company Profile

Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinical trial for patients with radiation-induced hemorrhagic cystitis; and LP-310, a formulation of tacrolimus for the treatment of oral lichen planus. The company was incorporated in 2005 and is based in Pittsburgh, Pennsylvania.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2022-12-19

Beta

1.06

Websitewww.lipella.com↗